Form 4: Angiodynamics Executive Receives Stock Grant
Insider Transaction (Form 4)
Chad Thomas Campbell, SVP/GM, Vascular Access of Angiodynamics Inc, reported multiple transactions in common stock on July 15, 2026.
Summary
- Grant/award: acquired 16,081 Common Stock on July 15, 2026; holds 104,540 after (Direct).
- Grant/award: acquired 16,081 Performance Right on July 15, 2026; holds 16,081 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Chad Thomas Campbell — Officer (SVP/GM, Vascular Access)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-15 | Grant/award | Common Stock | 16,081 | — | — | 104,540 |
| 2026-07-15 | Grant/award | Performance Right | 16,081 | — | — | 16,081 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-15 | Grant/award (16,081 shares) |
| 2026-07-15 | Grant/award (16,081 shares) |
Keywords
insider transaction, Form 4, ANGO, ANGIODYNAMICS INC, neutral, Chad Thomas Campbell
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.